Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 12;10(11):e038953.
doi: 10.1136/bmjopen-2020-038953.

Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study

Affiliations

Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study

Jane Frankland et al. BMJ Open. .

Abstract

Objectives: To describe prevalence and predictors of poor sexual well-being for men and women over 5 years following treatment for colorectal cancer.

Design: Prospective longitudinal study, from presurgery to 5 years postsurgery, with eight assessment points. Logistic regression models predicted sexual well-being from presurgery to 24 months and 24 months to 60 months; time-adjusted then fully adjusted models were constructed at each stage.

Setting: Twenty-nine hospitals in the UK.

Participants: Patients with Dukes' stage A-C, treated with curative intent, aged ≥18 years and able to complete questionnaires were eligible.

Outcome measures: The dependent variable was the Quality of Life in Adult Cancer Survivors sexual function score. Independent variables included sociodemographic, clinical and psychosocial characteristics.

Results: Seven hundred and ninety participants provided a sexual well-being score for at least one time point. Thirty-seven per cent of men and 14% of women reported poor sexual well-being at 5 years. Baseline predictors for men at 24 months included having a stoma (OR 1.5, 95% CI 1.02 to 2.20) and high levels of depression (OR 2.69/2.01, 95% CI 1.68 to 4.32/1.12 to 3.61); men with high self-efficacy (OR confident 0.33/0.48, 95% CI 0.18 to 0.61/0.24 to 1.00; very confident 0.25/0.42, 95% CI 0.13 to 0.49/0.19 to 0.94) and social support (OR 0.52/0.56, 95% CI 0.33 to 0.81/0.35 to 0.91) were less likely to report poor sexual well-being. Predictors at 60 months included having a stoma (OR 2.30/2.67, 95% CI 1.22 to 4.34/1.11 to 6.40) and high levels of depression (OR 5.61/2.58, 95% CI 2.58 to 12.21/0.81 to 8.25); men with high self-efficacy (very confident 0.14, 95% CI 0.047 to 0.44), full social support (OR 0.26; 95% CI 0.13 to 0.53) and higher quality of life (OR 0.97, 95% CI 0.95 to 0.98) were less likely to report poor sexual well-being. It was not possible to construct models for women due to low numbers reporting poor sexual well-being.

Conclusions: Several psychosocial variables were identified as predictors of poor sexual well-being among men. Interventions targeting low self-efficacy may be helpful. More research is needed to understand women's sexual well-being.

Keywords: adult oncology; gastrointestinal tumours; health services administration & management; oncology; quality in health care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Deborah Fenlon has received an honorarium from Roche.

Figures

Figure 1
Figure 1
Prevalence of poor sexual well-being among men and women over the 5 years from presurgery baseline, showing 95% CIs.

Similar articles

Cited by

References

    1. Albaugh JA, Tenfelde S, Hayden DM. Sexual dysfunction and intimacy for Ostomates. Clin Colon Rectal Surg 2017;30:201–6. 10.1055/s-0037-1598161 - DOI - PMC - PubMed
    1. Averyt JC, Nishimoto PW. Addressing sexual dysfunction in colorectal cancer survivorship care. J Gastrointest Oncol 2014;5:388–94. 10.3978/j.issn.2078-6891.2014.059 - DOI - PMC - PubMed
    1. Canty J, Stabile C, Milli L, et al. . Sexual function in women with Colorectal/Anal cancer. Sex Med Rev 2019;7:202–22. 10.1016/j.sxmr.2018.12.001 - DOI - PMC - PubMed
    1. Donovan KA, Thompson LMA, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control 2010;17:44–51. 10.1177/107327481001700106 - DOI - PubMed
    1. Ho VP, Lee Y, Stein SL, et al. . Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum 2011;54:113–25. 10.1007/DCR.0b013e3181fb7b82 - DOI - PubMed

Publication types